Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Neurofibromatosis 1 × Cholecalciferol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 9 Breast Neoplasms 7 Myelodysplastic Syndromes 4 Vitamin D Deficiency 3 Leukemia, Myeloid, Acute 3 Leukemia 3 Rectal Neoplasms 2 Polycystic Ovary Syndrome 2 Ovarian Neoplasms 2 Myeloproliferative Disorders 2 Myelodysplastic-Myeloproliferative Diseases 2 Male Urogenital Diseases 2 Colonic Neoplasms 2 Warts 1 Triple Negative Breast Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Pain 1 Osteoporosis 1 Obesity 1 Neurofibromatosis 1 1 Neuralgia 1 Lymphoma, Non-Hodgkin 1 Lymphoma 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myelomonocytic, Acute 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Monocytic, Acute 1 Leukemia, Megakaryoblastic, Acute 1

Interventions

AZD 6244 9 trametinib 3 Lovastatin 3 mirdametinib 2 Sirolimus 2 Inhalation 2 Everolimus 2 Acetylcysteine 2 tipifarnib 1 thymoglobulin 1 pirfenidone 1 peginterferon alfa-2b 1 omipalisib 1 fludarabine 1 cediranib 1 binimetinib 1 Vitamin D 1 Vincristine 1 Vinblastine 1 Temozolomide 1 Sunitinib 1 Saline Solution 1 Rituximab 1 Radiotherapy 1 Photochemotherapy 1 Methotrexate 1 Melphalan 1 Levetiracetam 1 Lenalidomide 1 Lamotrigine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01968590 2022-05-25

VitDBoneNF1

University of Utah

Phase 2 Terminated

Neurofibromatosis 1

Data powered by HemOnc (CC BY 4.0) Colophon ⚡